Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated

Haematologica

Volumn 94, Issue 5, 2009, Pages 629-637

  Noy Lotan, Sharon ^a   Dgany, Orly ^a   Lahmi, Roxane ^a,b   Marcoux, Nathaly ^a   Krasnov, Tanya ^a   Yissachar, Nissan ^b   Ginsberg, Doron ^b   Motro, Benny ^b   Resnitzky, Peretz ^c   Yaniv, Isaac ^e   Kupfer, Gary M ^d   Tamary, Hannah ^a,e  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c KAPLAN HOSPITAL   (Israel)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Cell cycle; Codanin 1; E2F; Heterochromatin

Indexed keywords

CODANIN 1; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BINDING SITE; CDAN1 GENE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRUCTURE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME CONDENSATION; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 1; ERYTHROBLAST; ERYTHROPOIESIS; GENE; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; E2F1 TRANSCRIPTION FACTOR; G2 PHASE; GENE EXPRESSION; GLYCOPROTEINS; HELA CELLS; HETEROCHROMATIN; HUMANS; LEUPEPTINS; LUCIFERASES; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; TAMOXIFEN;

EID: 66049133297     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2008.003327     Document Type: Article

References (33)

1. Heimpel H, Wendt F. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta 1968;34:103-115
2. Gasparini P, Miraglia del Giudice E, Delaunay J, Totaro A, Granatiero M, Melchionda S, et al. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. Am J Hum Genet 1997;61:1112-1116
3. Sandstrom H, Wahlin A. Congenital dyserythropoietic anemia type III. Haematologica 2000;85:753-757 (Pubitemid 30617110)
4. Lind L, Sandstrom H, Wahlin A, Eriksson M, Nilsson-Sojka B, Sikstrom C, et al. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. Hum Mol Genet 1995;4:109-112
5. Delaunay J, Iolascon A. The congenital dyserythropoietic anaemias. Baillieres Best Pract Res Clin Haematol 1999;12:691-705. (Pubitemid 30389479)
6. Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Eidelitz-Markus T, et al. Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Br J Haematol 2005;130:628-634
7. Tamary H, Shalev H, Luria D, Shaft D, Zoldan M, Shalmon L, et al. Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood 1996;87:1763-1770
8. Wickramasinghe S, Pippard M. Studies of erythroblast function in congenital dyserythropoietic anaemia, type I: evidence of impaired DNA, RNA, and protein synthesis and unbalanced globin chain synthesis in ultrastructurally abnormal cells. J Clin Pathol 1986;39:881-890 (Pubitemid 16050546)
9. Queisser W, Spiertz E, Jost E, Heimpel H. Proliferation disturbances of erythroblasts in congenital dyserythropoietic anemia type I and II. Acta Haematol 1971;45:65-76.
10. Tamary H, Shalmon L, Shalev H, Halil A, Dobrushin D, Ashkenazi N, et al. Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome chromosome 15q15.1-15.3. Am J Hum Genet 1998;62:1062-1069
11. Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H, et al. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 2002;71:1467-1474
12. Heimpel H, Schwarz K, Ebnother M, Goede JS, Heydrich D, Kamp T, et al. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 2006;107:334-340
13. Pielage J, Stork T, Bunse I, Klambt C. The Drosophila cell survival gene discs lost encodes a cytoplasmic Codanin-1-like protein, not a homolog of tight junction PDZ protein Patj. Dev Cell 2003;5:841-851 (Pubitemid 37527685)
14. Qiao F, Moss A, Kupfer GM. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J Biol Chem 2001;276:23391-23396 (Pubitemid 37410723)
15. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-327
16. Resnitzky P, Shaft D. Distinct lysozyme content in different subtypes of acute myeloid leukaemic cells: an ultrastructural immunogold study. Br J Haematol 1994;88:357-363 (Pubitemid 24318186)
17. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 1999;19:6379-6395
18. Hershko T, Korotayev K, Polager S, Ginsberg D. E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1. J Biol Chem 2006;281:31309-31316 (Pubitemid 46041395)
19. Grewal SI, Jia S. Heterochromatin revisited. Nat Rev Genet 2007;8:35-46. (Pubitemid 46006048)
20. Delcuve GP, He S, Davie JR. Mitotic partitioning of transcription factors. J Cell Biochem 2008;105:1-8.
21. Martinez-Balbas MA, Dey A, Rabindran SK, Ozato K, Wu C. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 1995;83:29-38.
22. Muchardt C, Reyes JC, Bourachot B, Leguoy E, Yaniv M. The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J 1996;15:3394-3402 (Pubitemid 26231946)
23. Sif S, Stukenberg PT, Kirschner MW, Kingston RE. Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. Genes Dev 1998;12:2842-2851 (Pubitemid 28440143)
24. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006;25:5220-5227 (Pubitemid 44299080)
25. Korotayev K, Chaussepied M, Ginsberg D. ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry. Cell Signal 2008;20:1221-1226
26. Muller H, Helin K. The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 2000;1470:M1-12. (Pubitemid 30070163)
27. Polager S, Kalma Y, Berkovich E, Ginsberg D. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 2002;21:437-446 (Pubitemid 34123806)
28. Ciemerych MA, Kenney AM, Sicinska E, Kalaszczynska I, Bronson RT, Rowitch DH, et al. Development of mice expressing a single D-type cyclin. Genes Dev 2002;16:3277-3289
29. Humbert PO, Rogers C, Ganiatsas S, Landsberg RL, Trimarchi JM, Dandapani S, et al. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell 2000;6:281-291
30. Kinross KM, Clark AJ, Iazzolino RM, Humbert PO. E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood 2006;108:886-895 (Pubitemid 44154621)
31. Li FX, Zhu JW, Hogan CJ, DeGregori J. Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice. Mol Cell Biol 2003;23:3607-3622 (Pubitemid 36539193)
32. Rempel RE, Saenz-Robles MT, Storms R, Morham S, Ishida S, Engel A, et al. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol Cell 2000;6:293-306.
33. von Lindern M. Cell-cycle control in erythropoiesis. Blood 2006;108:781-782 (Pubitemid 44154600)